# Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)

> **NCT00655343** · PHASE3 · COMPLETED · sponsor: **Neovii Biotech** · enrollment: 202 (actual)

## Conditions studied

- Graft vs Host Disease

## Interventions

- **DRUG:** ATG-Fresenius S

## Key facts

- **NCT ID:** NCT00655343
- **Lead sponsor:** Neovii Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2007-03
- **Final completion:** 2009-03
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2011-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655343, "Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00655343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*